Well Lead Medical603309.SHValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Well Lead Medical (603309.SH) trades at a P/E of 54.00x, P/B of 1.75x, P/S of 2.02x, and a dividend yield of 4.69%.
Longitudinal percentile comparison: P/E sits at the 84th percentile over the trailing 10Y window (vs. 82nd percentile over 3Y); P/B sits at the 3rd percentile over the trailing 10Y window (vs. 9th percentile over 3Y); P/S sits at the 0th percentile over the trailing 10Y window (vs. 1st percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 62nd percentile within its industry and the 63rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 4.69%, ranking at the 99th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 80.7 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Well Lead Medical operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHA: 603309 · SSE: 603309 · 603309
Want the full picture on whether Well Lead Medical (603309.SH) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 54.00 | ||||||
| P/B (MRQ) | 1.75 | ||||||
| P/S (TTM) | 2.02 | ||||||
| Dividend Yield | 4.69% | ||||||
| Buyback + Div Yield | 4.69% |